Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone-marrow transplantation Journal Article

Authors: Jules-Elysee, K.; Stover, D. E.; Yahalom, J.; White, D. A.; Gulati, S. C.
Article Title: Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone-marrow transplantation
Abstract: To define the incidence and spectrum of pulmonary complications following autologous bone marrow transplantation (BMT), we retrospectively reviewed the course of 77 consecutive patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) who failed conventional therapy and underwent autologous BMT. Forty-five percent of the 77 patients developed respiratory complications with a mortality from pulmonary causes of 26%. A total of 38 episodes of respiratory compromise occurred in 35 patients. Infections accounted for 15 episodes (39%) and included bacterial (16%), Aspergillus (8%) cytomegalovirus (8%), Herpes simplex (3%), and other (5%) pneumonias. The spectrum of infections was similar to that reported following allogeneic BMT, but cytomegalovirus pneumonia was not as frequent a problem in those with autologous transplant. Mortality from pulmonary infections was 33%. Noninfectious disorders accounted for 23 episodes (61%) and included recurrent HD (18%), radiation/drug toxicity (16%), and acute respiratory failure thought secondary to pulmonary alveolar hemorrhage (26%). This latter entity developed acutely within 2 wk following BMT and was associated with use of thoracic radiation for treatment of malignant disease in the chest just prior to BMT (p < 0.05). It was not associated with the age of the patient or presence of thrombocytopenia, coagulopathy, renal insufficiency or neutropenia (p NS). Mortality from noninfectious causes was 65%, but in those with pulmonary hemorrhage it was 100%. In conclusion, pulmonary complications are a major source of morbidity and mortality in patients with HD and NHL undergoing autologous BMT. In spite of the less severe immunosuppression anticipated, the nature of the malignant disorders requiring high-dose chemotherapy in combination with intrathoracic radiation lead to a high incidence of noninfectious complications with significant mortality. A fatal syndrome of acute respiratory failure associated with alveolar hemorrhage is of particular concern in this group of patients and warrants further investigation.
Keywords: chemotherapy; pneumonia; diagnosis; experience; host; bronchoalveolar lavage; hodgkins-disease; recipients; diffuse alveolar hemorrhage
Journal Title: American Review of Respiratory Disease
Volume: 146
Issue: 2
ISSN: 0003-0805
Publisher: Amer Lung Assoc  
Date Published: 1992-08-01
Start Page: 485
End Page: 491
Language: English
ACCESSION: WOS:A1992JP34800038
DOI: 10.1164/ajrccm/146.2.485
PUBMED: 1489145
Notes: Source: Wos
Citation Impact
MSK Authors
  1. Joachim Yahalom
    508 Yahalom
  2. Dorothy A White
    74 White
  3. Subhash C. Gulati
    123 Gulati